Reference : Do Positive Cardiovascular Outcomes Trials With New Glucose-Lowering Agents Overestim...
Scientific journals : Letter to the editor
Human health sciences : Pharmacy, pharmacology & toxicology
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/229827
Do Positive Cardiovascular Outcomes Trials With New Glucose-Lowering Agents Overestimate Both Efficacy and Safety?
English
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques >]
2018
Circulation Research
NLM (Medline)
123
4
e3-e4
Yes (verified by ORBi)
00097330
15244571
[en] [No abstract available]
http://hdl.handle.net/2268/229827
10.1161/CIRCRESAHA.118.313485

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
CIRCRES2018313485.pdfAuthor postprint123.62 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.